Preventing Heart Attacks and Strokes in High Need Areas

The summary for the Preventing Heart Attacks and Strokes in High Need Areas grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.

Preventing Heart Attacks and Strokes in High Need Areas: The purpose of this one-year funding announcement is for the MS Delta Health Collaborative (MDHC) to complete existing activities that aim to prevent heart disease, stroke, and related chronic diseases, and would otherwise not be done because of limited time and funds. This program will continue to intensify collaboration among the Mississippi Department of Health, existing chronic disease programs (e.g., heart disease and stroke prevention, diabetes, tobacco, nutrition, physical activity), local health departments, other community health care providers (e.g., Federally Qualified Health Centers), local communities, and the CDC. MDHC will continue to implement interventions that focus on priority populations across Mississippi's 18-county Delta Region and address "ABCS" (i.e., Aspirin therapy, Blood pressure control, Cholesterol management, Smoking cessation, and Smoke-free ordinances). MDHC will continue to address and/or complete seven key recipient activities: 1) Program Infrastructure, Staffing, Management and Support; 2) Fiscal Management; 3) Leadership Team, Partnership Development, and Maintenance; 4) Implementation of Clinical Interventions; 5) Implementation of Community-Based Educational, Policy, and Systems Interventions; 6) Program Evaluation and Surveillance; and 7) Collaboration with other Chronic Disease Programs.